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Previewsactivation in mouse embryonic fibroblasts
and human umbilical vein endothelial cells
(Kasper et al., 2010). Systematic studies of
bystander activation in different infected
tissues will be of significant interest for
understanding bacterial pathogenesis
and host response to infection.
In conclusion, bystander cell activation
may shift the paradigm of epithelial cell
function in infectious disease. This mech-
anism transforms our view of the innate
immune response and may have a broad
relevance for innate immune defense
against intracellular pathogens. The direct
communication between infected and654 Immunity 33, November 24, 2010 ª2010noninfected cells of an infected tissue rai-
ses numerous questions for cell biology,
immunology, and bacterial pathogenesis.REFERENCES
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In this issue of Immunity, Bao et al. (2010) provide in vivo evidence that heparan sulfate glycosaminoglycans
(GAGs) are indispensable for immobilization and function of major chemokines required for leukocyte adhe-
sion to and crossing through blood and lymphatic vessels.Chemokines are structurally related che-
motactic cytokines (chemoattractants)
with remarkable functional versatility
(Bromley et al., 2008). Chemokines signal
through cognate G protein coupled
receptors (GPCRs) either at their soluble
or immobilized states. However, a direct
in vivo proof for their functions in soluble
versus immobilized states has been diffi-
cult to obtain, because soluble chemo-
kines are readily removed by conventional
histological analysis. Thus, a genetic
interference with chemokine immobiliza-
tion has been necessary in order to
dissect the significance of immobilization
for particular adhesive and migratory
processes.
Leukocyte extravasation from blood
involves sequential chemoattractant-
mediated signals. Chemokines stably im-
mobilized on surface proteoglycans on
the luminal surface of endothelial cells
were suggested to play a pivotal role in in-tegrin-mediated arrest of rolling leukocytes
(Ley et al., 2007). Additional chemokine
signals were suggested to promote crawl-
ing of leukocytes across endothelium,
protrusion, and encounter of abluminal
chemokines (Ley et al., 2007). Chemokine
immobilizationonvascularendothelial cells
and adherent platelets was suggested to
be critical not only to prevent their dilution
by blood flow but also to facilitate localized
signaling to integrins on rolling leukocytes.
In addition, stroma-immobilized chemo-
kines efficiently promote motility of
lymphocytes and dendritic cells (DCs) in
specificareasof lymphoid tissues (Bajenoff
et al., 2006). However, it is still unclear
whether chemokines that direct leukocyte
motility and chemotaxis in various intersti-
tial spaces as well as across epithelial
barriers operate in their soluble or immobi-
lized states (Schumann et al., 2010).
Most chemokines share a carboxyl
terminus stretch of positively chargedresidues that recognize heparan sulfate
(HS) GAGs with moderate affinities
(Proudfoot, 2006; Rot and von Andrian,
2004). HS GAGs are ubiquitous and
structurally diverse macromolecules that
interact with many cytokines, growth
factors, and extracellular matrix (ECM)
components. In vitro and in vivo studies
on leukocyte interactions with various
endothelial cells have suggested that
many chemokines immobilize, and at
times also oligomerize on, HS GAGs
(Proudfoot, 2006). The first in vivo
involvement of endothelial heparan sul-
fate in inflammation was genetically
supported by elegant endothelial-tar-
geted ablation of the enzyme required
for N-sulfation of HS GAGs (Wang et al.,
2005). Attenuated neutrophil infiltration
to sites of inflammation was reported
in these mice but was attributed to
combined inhibition of chemokine trans-
cytosis across endothelial cells,
Figure 1. Postulated Roles for Endothelial HS Proteoglycans in Chemokine Immobilization
on Vascular and Lymphatic Endothelia
To activate integrins on rolling leukocytes, chemokines must be immobilized on HS GAGs of the endothe-
lial glycocalyx (enlarged, inset). These GAGs can reduce, on the other hand, the strength of rolling adhe-
sions. Chemokine transcytosis across the venule involves chemokine binding to subendothelial DARC or
a related nonsignaling GPCR and to HS GAGs. Leukocyte sticking and crawling are followed by chemo-
kine-triggered cell protrusions that sense HS GAG-immobilized chemokines within the ECM of the base-
ment membrane.
Immunity
Previewschemokine presentation on lumenal
aspects of inflamed blood vessels, and
to reduced expression of atypical endo-
thelial L-selectin ligands necessary for
optimal neutrophil rolling (Wang et al.,
2005). The involvement of HS GAGs in
chemokine immobilization on endothelial
cells was demonstrated in that study
only in vitro and so, direct in vivo
evidence that HS GAGs immobilize
endogenous chemokines has been
missing. Such evidence has been espe-
cially necessary for lymphoid organ che-
mokines, because a major chemokine in
this subgroup, the CCR7 ligand CCL21,
was reported to also bind chondroitin
sulfate GAGs (Rot and von Andrian,
2004; Miyasaka and Tanaka, 2004) as
well as to ECM proteins, like collagen
IV, and to a specialized scaffold,
MAC25, within basement membranes of
high endothelial venules (HEVs) (Miya-
saka and Tanaka, 2004).
In this milestone in vivo study, Bao et al.
(2010) temporally deleted the entire
heparan sulfate glycans from all endothe-
lial beds in a mouse model. The authors
inactivated exostoses-1 (Ext1), a critical
factor in early steps of heparan sulfatebiosynthesis, with a drug-inducible
endothelial specific promoter (Bao et al.,
2010). Nearly total deletion of HS GAGs,
achieved in the HEVs of skin draining
and mesenteric lymph nodes, led to
abolished presentation of CCL21 as eval-
uated by immunofluorescence staining.
Accordingly, lymphocyte homing to
lymph nodes was severely reduced and
elegant intravital microscopy studies of
inguinal lymph nodes indicated that this
homing defect was due to loss of integrin
activation on rolling lymphocytes and not
to a defect in L-selectin-mediated rolling
(Figure 1). The authors confirmed normal
HEV architecture, together with retained
expression of the endothelial marker
PECAM-1, the LFA-1 integrin ligand,
ICAM-1, and of MECA-79, a sulfated
marker of HEV L-selectin ligands. Deletion
of Ext1 also abolished HEV presentation
of the inflammatory chemokine CCL2,
transported from extralymphoid tissues
(Bao et al., 2010).
The findings of Bao et al. (2010) further
suggest that CCL21 presentation on
lymphatic vessels is also HS GAG depen-
dent and is necessary for optimal DC
crossing of skin lymphatic vessels andImmunity 33, Nsubsequent entry into skin draining lymph
nodes. Because substantial DC transport
to lymph nodes remained intact in the
absence of lymphatic HS GAGs, addi-
tional roles of soluble forms of other
CCR7 ligands, secreted along the
lymphatic tree remain possible (Bromley
et al., 2008). This CCR7-dependent integ-
rin-independent route is also taken by
subsets of effector T cells, a process not
addressed in this study.
Bao et al. (2010) also provide in vivo
evidence for critical roles of endothelial
HS in the immobilization and function of
the inflammatory chemokine CXCL2 in
neutrophil extravasation to inflamed skin.
These results are consistent with previous
in vitro evidence that lung capillary HS
GAGs immobilize CXCL1 and CXCL2
and are critical for their transcytosis
(Wang et al., 2005). The results also
confirm a recent report on the role of HS
GAGs in immobilization of exogenous
CXCL2 on cremaster muscle venules
in vivo (Massena et al., 2010). Notably,
endothelial HS may also be necessary
for chemokine exocytosis from Weibel
Palade bodies, specialized granules that
release CXCL8 and CCL26 in response
to acute injury and allergic signals,
a possibility that could be readily ad-
dressed in this Ext1-deficient model.
Importantly, Est1 inactivation in endo-
thelial cells also abolished the decoration
of functional HS moieties on endothelial
secreted proteoglycans. Consequently,
the basementmembranes of both venules
and lymphatic vessels testedwas found to
lack HS GAGs, whereas other stromal-
derived GAGs such as lymph node fibro-
blastic reticular cells expressed intact HS
and normally immobilized CCL21 (Bao
et al., 2010). Intranodal migration of
dendritic cells was therefore not affected,
consistent with the dependence of this
motility on stroma-presented and soluble
CCR7 ligands.
In spite of these versatile functions of
HS GAGs in different types of endothelial
cells and basement membranes, it is still
possible that many extravasation pro-
cesses involve HS-independent mecha-
nisms. For instance, several key lipid
chemoattractants like PAF, leukotrienes,
S1Ps, or 2-AG seem to immobilize directly
on endothelial surfaces. Furthermore, as
the density of endothelial HS is down-
regulated by HS-degrading enzymes
during progressive inflammation,ovember 24, 2010 ª2010 Elsevier Inc. 655
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Previewsendothelial cells may directly secrete the
chemokine they transcribe into tight
synapses generated by adherent and
transmigrating leukocytes.
Baoet al. (2010) report that in addition to
serving as critical chemokine scaffolds,
HSGAGs antagonize L-selectin-mediated
rolling of lymphocytes on HEVs. HS GAGs
were reported to decorate a nonfucosy-
lated L-selectin ligand expressed by in-
flamed lung capillaries (Wang et al.,
2005), yet this ligand and related HS
ligandsare either absent inHEVsor diluted
out by the prototypic HEV L-selectin
ligands, decorated with sulfated sLex.
Furthermore, the HEV-expressed HS
GAGs negatively regulate the adhesive-
ness of the prototypic sulfated sLex-deco-
rated L-selectin ligands, probably via
steric hindrance and electrostatic repul-
sion (Baoet al., 2010). Itwouldbe therefore
interesting to test in the futurewhether and
where HS-GAG-mediated electrostatic
repulsion can downregulate additional
leukocyte-endothelial interactions in
endothelial beds other than HEVs.
The apparently preserved structure of
Ext1-deleted blood and lymphatic vessels
suggest that temporal deletion of HS does
not impair basal signaling from critical
endothelial growth factors known to bind656 Immunity 33, November 24, 2010 ª2010HS GAGs. The endothelial conditional
Ext1-deficient mice generated by Bao
et al. (2010) will therefore be useful for
future dissection of the roles of HS-che-
mokine interactions within other vascular
beds, such as the bone marrow, thymus,
spleen, gut, and lung. Similar approaches
should be adopted to conditionally knock
down HS biosynthesis in other chemo-
kine-presenting cells such as epithelial
cells, nerves, fibroblasts, pericytes,
smooth muscle cells, and platelets (Ley
et al., 2007; Rot and von Andrian, 2004).
Furthermore, although HS GAGs on
lymphocytes (Bao et al., 2010) and
neutrophils (Wang et al., 2005) do not
contribute to their inflammatory functions,
subsets of DCs and macrophages
may need to immobilize the chemokines
they secrete within particular immune
synapses. HS GAGs on subsets of
leukemic cells may also promote
autocrine chemokine activities essential
for adhesion, motility, and survival. Inter-
ference with chemokine presentation on
HS GAGs expressed by these various
cellular systems could therefore be thera-
peutically promising for the manipulation
of specific chemokine functions in
different inflammatory and malignant
processes.Elsevier Inc.REFERENCES
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